Servier Canada wins patent case against Apotex's generic Coversyl
This article was originally published in Scrip
Executive Summary
Servier Canadahas won a patent infringement action against Apotex to stop the latter marketing a generic version of Servier's ACE-inhibitor Coversyl (perindopril).